| Literature DB >> 26136150 |
Raymond C K Chan1, Shan Dai2, Simon S Y Lui1,3,4, Karen K Y Ho3, Karen S Y Hung3, Ya Wang1, Fu-Lei Geng1,3, Zhi Li1,3, Eric F C Cheung4.
Abstract
The present study examined different types of neurological signs in patients with first-episode schizophrenia and their relationships with neurocognitive functions. Both cross-sectional and longitudinal designs were adopted with the use of the abridged Cambridge Neurological Inventory which comprises items capturing motor coordination, sensory integration and disinhibition. A total of 157 patients with first-episode schizophrenia were assessed at baseline and 101 of them were re-assessed at six-month interval. A structural equation model (SEM) with invariance model across time was used for data analysis. The model fitted well with the data at baseline assessment, X^2(21) = 21.78, p = 0.413, NFI = 0.95, NNFI = 1.00, CFI = 1.00, IFI = 1.00, RMSEA = 0.015. Subsequent SEM analysis with invariance model at six-month interval also demonstrated the same stable pattern across time and showed strong measurement invariance and structure invariance across time. Our findings suggest that neurological signs capture more or less the same construct captured by conventional neurocognitive tests in patients with schizophrenia. The measurement and structure of these relationships appear to be stable over time.Entities:
Mesh:
Year: 2015 PMID: 26136150 PMCID: PMC4650684 DOI: 10.1038/srep11850
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Description of the samples at baseline and matched follow-up at 6-month interval.
| Patients at baseline (N = 157) (Mean, SD) | Patients at baseline (N = 101) (Mean, SD) | Patients at 6-month interval (N = 101) (Mean, SD) | T-tests | |
|---|---|---|---|---|
| Age (years) | 24.39,6.12 | 24.51,6.23 | 24.51,6.23 | – |
| Education (years) | 11.61,2.15 | 11.60,2.11 | 11.60,2.11 | – |
| Gender (F:M) | 82:75 | 51:50 | 51:50 | |
| Duration of illness (months) | 3.63,4.99 | 3.55,5.26 | – | – |
| Medication(Chlorpromazine equivalence) (mg/day) | 1.49,2.14 | 1.65,2.36 | – | |
| PANSS | – | – | ||
| Positive symptoms | 11.40,4.74 | 10.98,4.37 | 8.38,2.92 | 5.29 |
| Negative symptoms | 12.42,5.78 | 12.33,6.10 | 11.53,6.12 | 1.52 |
| General psychopathology | 22.96,6.45 | 22.80,6.69 | 19.73,4.85 | 4.10 |
| NSS scores | 6.10,3.11 | 5.83,3.12 | 4.72,2.98 | 4.00 |
| Motor coordination | 2.80,1.88 | 2.68,1.90 | 1.92,1.75 | 4.11 |
| Sensory integration | 2.11,1.46 | 2.00,1.44 | 1.46,1.31 | 3.62 |
| Disinhibition | 1.18,1.06 | 1.15,1.09 | 1.35,1.14 | –1.67 |
| Neurocognitive Functions | – | – | – | |
| WCST categories | 5.08,1.53 | 4.96,1.62 | 5.65,1.05 | –4.36 |
| Verbal fluency | 17.22,4.76 | 17.33,4.80 | 17.74,5.45 | –0.80 |
| Logical memory-immediate recall | 7.88,3.57 | 7.83,3.41 | 9.17,3.80 | –4.77 |
| Logical memory- delayed recall | 5.99,3.44 | 5.99,3.61 | 7.51,3.83 | –5.53 |
| Visual reproduction- immediate recall | 20.38,3.12 | 20.61,3.08 | 20.82,3.09 | –0.71 |
| Visual reproduction- delayed recall | 19.82,3.45 | 20.08,3.30 | 20.01,4.03 | 0.20 |
Note:*p < 0.05
Figure 1The structure model at baseline.
X^2(21) = 21.78, p = 0.413, NFI = 0.95, NNFI = 1.00, CFI = 1.00, IFI = 1.00, RMSEA = 0.015.
Tests for measurement invariance across time.
| Model | df | Δdf | Δ | P | NNFI | ΔNNFI | CFI | ΔCFI | RMSEA | ΔRMSEA |
|---|---|---|---|---|---|---|---|---|---|---|
| M1 Configural invariance | 104 | — | — | 0.121 | 0.981 | — | 0.987 | — | 0.040 | — |
| M2 Metric invariance | 112 | 8 | 14.101 | 0.067 | 0.976 | −0.005 | 0.983 | −0.005 | 0.045 | 0.005 |
| M3 Scalar invariance | 117 | 5 | 0 | 0.120 | 0.982 | 0.006 | 0.986 | 0.004 | 0.039 | −0.006 |
| M4 Error variance invariance | 126 | 9 | 24.873 | 0.022 | 0.969 | −0.013 | 0.974 | −0.012 | 0.052 | 0.013 |
| M5 Invariant factor variances | 121 | 4 | 11.219 | 0.058 | 0.976 | −0.006 | 0.981 | −0.006 | 0.046 | 0.006 |
| M6 Invariant factor covariance | 124 | 3 | 6.977 | 0.038 | 0.973 | −0.003 | 0.978 | −0.003 | 0.049 | 0.003 |
| M7 Latent mean invariances | 128 | 4 | 0 | 0.063 | 0.977 | 0.005 | 0.981 | 0.003 | 0.045 | −0.004 |
Note: df – Degrees of freedom; Δdf –change in degrees of freedom,CFI - Comparative Fit Index; ΔCFI- change in Comparative Fit Index; NFI- Nonnormed Fit Index; ΔNNFI - change in Nonnormed Fit Index; RMSEA = Root Mean Square Error of Approximation; ΔRMSEA = change in Root Mean Square Error of Approximation.
Nested models were tested to determine whether the structure of neurological signs and conventional neurocognitive tests were operating equivalently across time.
Constraints and steps of measurement invariance.
| Tests | Constraints | Meaning | Interpretation |
|---|---|---|---|
| Configural invariance | No constraints | Same pattern | Same model structure across time |
| Metric invariance | Λ1 = Λ2=… | Equally constrained matrices of factor loadings | Same metric across time |
| Scalar invariance | Equally constrained vector with item intercepts | Same systematic response bias across time | |
| Invariance of error variances | Θ1 = Θ2=… | Equally constrained matrix with residuals variances | Same internal consistency across time |
| Invariance of factor variances | Equivalence of construct variance | Same heterogeneity of constructs across time | |
| Invariance of factor covariance | Equivalence of construct covariance | Same relationships among constructs across time | |
| Invariance of latent means | Equivalence of latent means | Same mean level of each constructs across time |
Figure 2The structure model of test for Factor variance and covariance invariance of measurement invariance.
X^2(124) = 153.35, p = 0.038, NNFI = 0.97, CFI = 0.98, IFI = 0.98, RMSEA = 0.
Figure 3The structure model of test for Latent mean invariance of measurement invariance.
X^2(128) = 153.35, p = 0.063, NNFI = 0.98, CFI = 0.98, IFI = 0.98, RMSEA = 0.045.